Abstract #577: Dulaglutide improves kidney fibrosis biomarker levels in patients with type 2 diabetes and moderate-to-severe chronic kidney disease
Publication Title
European Association for the Study of Diabetes
Document Type
Presentation
Publication Date
9-23-2020
Clinical Institute
Kidney & Diabetes
Specialty/Research Institute
Endocrinology
Comments
Virtual Meeting